Phase 2 Study of TLK286 in Platinum Resistant Advanced Epithelial Ovarian Cancer

NCT00038428 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Telik